Lyell Immunopharma, Inc.
(NASDAQ: LYEL)
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
24.270 -
+0.240
(+1.00%)
Range
24.030 - 25.410
(5.74%)
Open
24.030
Previous Close
24.030
Bid Price
24.610
Bid Volume
3
Ask Price
24.760
Ask Volume
8
Volume
21,384
Value
315,400
Remark
-
Delayed prices. Updated at 30 Jan 2026 03:10.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
